Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

PP Karjalainen, P Porela, A Ylitalo… - European heart …, 2007 - academic.oup.com
Aim The aim of this study was to evaluate the antithrombotic treatment adopted after coronary
stenting in patients requiring long-term anticoagulation. Methods and results We analysed …

Bacterial signatures in thrombus aspirates of patients with myocardial infarction

T Pessi, V Karhunen, PP Karjalainen, A Ylitalo… - Circulation, 2013 - Am Heart Assoc
Background— Infectious agents, especially bacteria and their components originating from
the oral cavity or respiratory tract, have been suggested to contribute to inflammation in the …

Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment

PP Karjalainen, S Vikman, M Niemelä… - European heart …, 2008 - academic.oup.com
Aims Uninterrupted anticoagulation (UAC) is assumed to increase bleeding and access-site
complications. A common consensus is to postpone percutaneous coronary interventions (…

One‐year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry

…, T Kiviniemi, F Biancari, PP Karjalainen… - Clinical …, 2014 - Wiley Online Library
Background Most evidence regarding the efficacy and safety of the antithrombotic regimens
for patients with atrial fibrillation ( AF ) undergoing percutaneous coronary intervention with …

Renal sympathetic denervation for treatment of patients with atrial fibrillation: reappraisal of the available evidence

W Nammas, JKE Airaksinen, T Paana, PP Karjalainen - Heart Rhythm, 2016 - Elsevier
Afferent renal sympathetic nerve signaling regulates central sympathetic outflow. In this
regard, renal sympathetic denervation has emerged as a novel interventional strategy for …

Titanium-nitride-oxide-coated coronary stents: insights from the available evidence

PP Karjalainen, W Nammas - Annals of medicine, 2017 - Taylor & Francis
Coating of stent surface with a biocompatible material is suggested to improve stent safety
profile. A proprietary process was developed to coat titanium-nitride-oxide on the stent surface…

Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment

AP Annala, PP Karjalainen, P Porela, K Nyman… - The American journal of …, 2008 - Elsevier
Long-term warfarin therapy is assumed to increase bleeding and access site complications
after coronary angiography and it is often recommended to postpone invasive procedures to …

Renal sympathetic denervation for treatment of patients with heart failure: summary of the available evidence

…, J Koistinen, T Paana, PP Karjalainen - Annals of …, 2017 - Taylor & Francis
Heart failure syndrome results from compensatory mechanisms that operate to restore – back
to normal – the systemic perfusion pressure. Sympathetic overactivity plays a pivotal role in …

Titanium-nitride-oxide–coated versus everolimus-eluting stents in acute coronary syndrome: The randomized TIDES-ACS trial

…, AS Penaranda, B De Bruyne, PP Karjalainen… - Cardiovascular …, 2020 - jacc.org
Objectives This study sought to compare next-generation cobalt-chromium–based titanium-nitride-oxide
(TiNO)–coated stents with a platinum-chromium–based biodegradable polymer …

[PDF][PDF] A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE …

PP Karjalainen, M Niemelä, JK Airaksinen… - …, 2012 - researchgate.net
Aims: Titanium-nitride-oxide-coated bioactive stents (BAS) have demonstrated a favourable
outcome when compared with paclitaxel-eluting stents in patients with acute myocardial …